Log in to post a reply
Jun 14, 2018 04:56PM
I am so sorry you find yourself here among up. However, this is a good group to ask questions of.
I wanted to prepare you for the probability that your MO will recommend Chemo along with a targeted therapy drug called Herceptin. If your tumor was 5 mm or smaller, they often give you the choice but 8 mm (the size mine was), they want you to have the Herceptin. Your tumor size is what is known as a T1b. Studies indicate that T1b tumors have a better prognosis if Herceptin is given. Because studies in more advanced forms of Her2+ breast cancer show there is a synergy between chemo and Herceptin (meaning they are more effective when the two are combined), the thinking has been that even in smaller tumors. you still need that synergy. That may or may not hold true, One of our members, Deni1661, was involved in a small study trying to sort that out. But as of now, the standard is chemo + herceptin.
Even doing chemo, there are several different options which your MO will go over with you. I did what was known as TCHP (Taxotere, Carboplatin, Herceptin and Perjeta (another targeted therapy drug for Her2+ ). I was supposed to have this cocktail every three weeks for 6 sessions, but my MO pulled the plug at 4. I then had two more rounds of H&P and then continued on for 12 more cycles of just Herceptin.
You may be offered a chemo called Taxol with Herceptin. Taxol is given weekly for 12 weeks. I asked my MO why that was not offered to me and she told me that the study had not yet matured. Recently, the results of this study showed the results for 7 years (maybe even 8) and they were very good. Most of the individuals in that study had tumors less the 2 cm and were node negative. I think my MO would have suggested this regimen had the study results been available when I was diagnosed.
It's possible your MO will say no chemo, but I would guess he will definitely suggest Herceptin. Best of luck.
7/5/2016, IDC, Left, Stage IA, Grade 2, 0/2 nodes, ER+/PR+, HER2+ (IHC)
7/20/2016 Lumpectomy: Left
9/11/2016 Carboplatin (Paraplatin), Taxotere (docetaxel)
9/12/2016 Herceptin (trastuzumab)
9/12/2016 Perjeta (pertuzumab)
12/11/2016 Whole-breast: Breast